CN112956623A - Beverage for eliminating hangover symptoms - Google Patents
Beverage for eliminating hangover symptoms Download PDFInfo
- Publication number
- CN112956623A CN112956623A CN202110247090.4A CN202110247090A CN112956623A CN 112956623 A CN112956623 A CN 112956623A CN 202110247090 A CN202110247090 A CN 202110247090A CN 112956623 A CN112956623 A CN 112956623A
- Authority
- CN
- China
- Prior art keywords
- beverage
- vitamin
- hangover symptoms
- cysteine
- hangover
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 39
- 206010019133 Hangover Diseases 0.000 title claims abstract description 24
- 208000024891 symptom Diseases 0.000 title claims abstract description 19
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 17
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000018417 cysteine Nutrition 0.000 claims abstract description 17
- 229960003495 thiamine Drugs 0.000 claims abstract description 17
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 17
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 17
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 17
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a beverage capable of eliminating hangover symptoms, and belongs to the technical field of beverages, wherein the beverage contains cysteine and vitamin B1. The beverage has the advantages of few types of effective components, easy production and manufacture, good use effect, great market competitiveness and popularization and application value.
Description
Technical Field
The invention belongs to the technical field of beverages, and particularly relates to a beverage capable of eliminating hangover symptoms.
Background
Excessive drinking often leads to intoxication and, as a consequence, hangover. Hangover is a typical physical and mental stress syndrome and condition. Alcohol hangover is characterized by headache, trembling, nausea, diarrhea, and fatigue, combined with a decline in occupational, cognitive, or visuospatial skill performance. In addition, symptoms include fatigue, thirst due to dehydration, sweating, and tremor. Little is known about the pathophysiology of hangover. However, the level of alcoholism is known to be related to the degree of hangover, and not always to the amount of alcohol intake.
At present, no beverage capable of effectively eliminating hangover exists in the market.
Disclosure of Invention
The invention aims to provide a beverage capable of eliminating hangover symptoms.
The technical purpose of the invention is realized by the following technical scheme:
a beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Further, the weight percentage of the cysteine in the beverage is 0.01-1.5%.
Further, the weight percentage of the vitamin B1 in the beverage is 0.01-0.5%.
Compared with the prior art, the invention has the following advantages:
the invention provides a beverage capable of eliminating hangover symptoms, wherein cysteine and vitamin B1 are added into the beverage in a reasonable proportion, and the two components can well eliminate the influence of adverse components such as acetaldehyde on human bodies, supplement beneficial components for human bodies, improve the physical constitution of the human bodies and relieve and eliminate the hangover symptoms. The beverage has the advantages of few types of effective components, easy production and manufacture, good use effect, great market competitiveness and popularization and application value.
Detailed Description
Example 1
A beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Cysteine was present in the beverage in an amount of 0.01% by weight.
The weight percentage of the vitamin B1 in the beverage is 0.01%.
Example 2
A beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Cysteine was present in the beverage in an amount of 1% by weight.
The weight percentage of the vitamin B1 in the beverage is 0.2%.
Example 3
A beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Cysteine was present in the beverage in an amount of 1.5% by weight.
The weight percentage of the vitamin B1 in the beverage is 0.5%.
Example 4
A beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Cysteine was present in the beverage in an amount of 0.01% by weight.
The weight percentage of the vitamin B1 in the beverage is 0.5%.
Example 5
A beverage for relieving hangover symptoms comprises cysteine and vitamin B1.
Cysteine was present in the beverage in an amount of 1.5% by weight.
The weight percentage of the vitamin B1 in the beverage is 0.01%.
The invention provides a beverage capable of eliminating hangover symptoms, wherein cysteine and vitamin B1 are added into the beverage in a reasonable proportion, and the two components can well eliminate the influence of adverse components such as acetaldehyde on human bodies, supplement beneficial components for human bodies, improve the physical constitution of the human bodies and relieve and eliminate the hangover symptoms. The beverage has the advantages of few types of effective components, easy production and manufacture, good use effect, great market competitiveness and popularization and application value.
Claims (3)
1. A beverage for relieving hangover symptoms, which comprises cysteine and vitamin B1.
2. The beverage for relieving hangover symptoms according to claim 1, wherein the content of cysteine is 0.01 to 1.5% by weight in the beverage.
3. The beverage for relieving hangover symptoms as claimed in claim 1, wherein the vitamin B1 is contained in the beverage in an amount of 0.01 to 0.5% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110247090.4A CN112956623A (en) | 2021-03-05 | 2021-03-05 | Beverage for eliminating hangover symptoms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110247090.4A CN112956623A (en) | 2021-03-05 | 2021-03-05 | Beverage for eliminating hangover symptoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112956623A true CN112956623A (en) | 2021-06-15 |
Family
ID=76276746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110247090.4A Pending CN112956623A (en) | 2021-03-05 | 2021-03-05 | Beverage for eliminating hangover symptoms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112956623A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101862332A (en) * | 2009-04-20 | 2010-10-20 | 兰章华 | Composition for preventing human body injuries by excessive consumption of alcohol and preparation method and application thereof |
| CN109562090A (en) * | 2016-06-06 | 2019-04-02 | 凯达普特凯特有限公司 | For treating the composition of L- cysteine acid, ascorbic acid and the vitamin B3 be still drank after a night |
| US20190105293A1 (en) * | 2016-03-24 | 2019-04-11 | Phoenix Pharmaceuticals Australia Pty Ltd | Formulation and method for the prevention and/or treatment of hangover symptoms |
| CN109715168A (en) * | 2016-08-04 | 2019-05-03 | Ph股份公司 | For treating the composition being still drank after a night |
-
2021
- 2021-03-05 CN CN202110247090.4A patent/CN112956623A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101862332A (en) * | 2009-04-20 | 2010-10-20 | 兰章华 | Composition for preventing human body injuries by excessive consumption of alcohol and preparation method and application thereof |
| US20190105293A1 (en) * | 2016-03-24 | 2019-04-11 | Phoenix Pharmaceuticals Australia Pty Ltd | Formulation and method for the prevention and/or treatment of hangover symptoms |
| CN109562090A (en) * | 2016-06-06 | 2019-04-02 | 凯达普特凯特有限公司 | For treating the composition of L- cysteine acid, ascorbic acid and the vitamin B3 be still drank after a night |
| CN109715168A (en) * | 2016-08-04 | 2019-05-03 | Ph股份公司 | For treating the composition being still drank after a night |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pozo-Bayón et al. | Scientific evidences beyond the application of inactive dry yeast preparations in winemaking | |
| RU2397244C2 (en) | Composite yeast suitable for high concentration alcohol fermentation | |
| CN102443507B (en) | A kind of production technique of preparing rose wine with composite bio-enzyme | |
| CN107022446B (en) | Method for producing highland barley health-preserving wine by pre-treating and fermenting | |
| AU2021101601A4 (en) | Method for reducing methanol content in fruit wine and fruit wine with low methanol content | |
| CN103230053A (en) | Fruit-vinegar-type proanthocyanidin beverage and preparation method thereof | |
| Shin et al. | Fermentation characteristics of kochujang containing horseradish or mustard | |
| CN112956623A (en) | Beverage for eliminating hangover symptoms | |
| US20130224319A1 (en) | Compositions and Methods to Reduce Hangover and Reduce Blood Alcohol Levels After Alcohol Consumption | |
| EP3335718B1 (en) | Chinese medicine hangover curing agent | |
| CN102268353A (en) | Chinese wolfberry wine and preparation method thereof | |
| WO2014096876A1 (en) | Production of alcoholic beverage by blending fermented grape and pomegranate juice | |
| CN113122410A (en) | Method for simultaneously reducing accumulation of citrulline and ethyl carbamate in fermented food | |
| US20170174717A1 (en) | Method of separating betanin from red quinoa by supercritical fluid fractionation | |
| Zhou et al. | Study on process optimization and antioxidant activity of glutinous rice wine rich in active components of Dendrobium officinale. | |
| CN105296264A (en) | Blueberry and grape wine brewing method | |
| CN202348363U (en) | Valve clearance adjusting bolt | |
| CN1891808A (en) | Milk beer production method | |
| Muhammed et al. | Effects of tannic acid, ellagic acid, gallic acid and catechin on cellulose degradation by the rumen fungus Neocallimastix frontalis strain rel | |
| SILVA et al. | PRODUCTION AND EVALUATION OF GREEN TEA KOMBUCHA: INFLUENCE OF PROCESS VARIABLES ON PHYSICAL-CHEMICAL COMPOSITION AND ANTIOXIDANT ACTIVITY | |
| CN102994326A (en) | Red bayberry wine | |
| CN114672394B (en) | Method for reducing color of rice vinegar and rice vinegar | |
| CN110679843A (en) | Maca health food | |
| CN107988027A (en) | A kind of pure natural healthy rice wine | |
| CN115521927B (en) | Complex enzyme preparation capable of reducing content of higher alcohol and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210615 |